Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novyra Pharmachem Limited has filed a statement confirming no deviation or variation in the utilization of proceeds from a preferential issue. The company raised Rs. 13,24,500 through 1,76,600 partly paid-up equity shares which were converted to fully paid-up shares on 28th March 2025 and 9th June 2025. The entire amount was utilized for working capital requirements of the company. As of March 31, 2026, the paid-up share capital stands at Rs. 6,33,00,000 divided into 63,30,000 equity shares of Rs. 10 each. The Audit Committee reviewed and confirmed no comments on the utilization.
Routine compliance filing confirming proper utilization of funds as intended. The conversion of partly paid shares to fully paid-up increases the company's transparency and strengthens investor confidence.